SDC2 and rheumatoid arthritis: In rheumatoid arthritis -associated interstitial lung disease, elevated PAD2 expression in lung fibroblasts promoted a pro-fibrotic phenotype, while overexpression of syndecan-2 (SDC2) inhibited PAD2 and protected against BLM-induced fibrosis [94].